Method for Treating Phytophotodermatitis
US-2016030381-A1 · Feb 4, 2016 · US
US10363236B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10363236-B2 |
| Application number | US-201815973915-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 8, 2018 |
| Priority date | Jan 3, 2011 |
| Publication date | Jul 30, 2019 |
| Grant date | Jul 30, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
An isothiocyanate functional surfactant, wherein the protonated form of said surfactant is represented by the following chemical structure: wherein X includes an integer ranging from approximately 1 to approximately 25, and wherein Y includes an integer ranging from approximately 6 to approximately 25.
Opening claim text (preview).
What is claimed and desired to be secured by Letters Patent of the United States is: 1. A surfactant formulation, comprising: a lysine derivative, wherein the lysine derivative comprises an α-nitrogen and a ε-nitrogen, and wherein an alkyl and/or alkanoyl substituent comprising at least 8 carbon atoms is bound to the α-nitrogen, and further wherein the ε-nitrogen forms part of an isothiocyanate functional group. 2. A surfactant formulation, comprising: a surfactant or a pharmaceutically acceptable salt thereof, wherein the salt of the surfactant is represented by the following chemical structure: wherein R 1 is selected from the group consisting of an alkyl and alkanoyl group containing 1 to 25 carbon atom(s); wherein R 2 is selected from the group consisting of NCS; wherein R 3 -R 5 are each independently selected from the group consisting of H; OH; and an alkyl, and alkanoyl group containing 1 to 25 carbon atom(s) with the proviso that at least one of R 3 -R 5 is selected from the group consisting of an alkyl, and alkanoyl, group containing 8 to 25 carbon atoms; and wherein X + comprises a counter cation.
Drugs for dermatological disorders · CPC title
of a saturated carbon skeleton · CPC title
Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers (A61K47/10 takes precedence) · CPC title
Skin, i.e. galenical aspects of topical compositions (non-active ingredients are additionally classified in A61K47/00; A61K9/0009, A61K9/0021, A61K9/7015, A61K9/7023 take precedence; cosmetic preparations A61K8/00, A61Q; preparations for wound dressings or bandages A61L26/00) · CPC title
Alpha-amino acids, e.g. alanine or edetic acid [EDTA] (betaine A61K31/205; proline A61K31/401; tryptophan A61K31/405; histidine A61K31/4172; peptides not degraded to individual amino acids A61K38/00) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.